Clinical Trials Update: Feb. 4, 2008
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
456703
NEW YORK  - In a new report, US researchers describe the improvement in brain function that occurred in a patient with Alzheimer's disease just minutes after receiving an injection in the spine of the arthritis drug Enbrel (also known as etanercept).
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
749165
New studies shed some light on these controversial heart treatments, but many questions remain. What patients need to know.
402115
Two drugs provide good results in preliminary trials.
438501
Here's what a newly approved drug looks like.
319964
The embattled pharmaceutical industry announced its intention Thursday to publish more data about clinical drug trials, despite skepticism about whether the initiative will really increase transparency and improve drug safety.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.
753810
Amid growing concerns, the maker of the widely sold arthritis drug announced Monday that it will soon begin a major clinical trial to determine whether the drug is safe for long-term use.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
400180
Description: A new study finds that deaths in cancer drug trials have declined ten-fold, thanks to the development of drugs that are better targeted at the tumors themselves.
121268
EPIX initiates a safety trial and gets good efficacy data.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
362077
Clinical trial data released by pharmaceutical company Boehringer Ingelheim at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, on its experimental protease inhibitor tipranavir show that the drug is effective
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...